ContractClinical Trial Agreement • October 12th, 2020
Contract Type FiledOctober 12th, 2020FIRST AMENDMENT TO CLINICAL TRIALAGREEMENT BETWEEN Covance (previously known as CHILTERN INTERNATIONAL, S.R.O.), FAKULTNI NEMOCNICE HRADEC KRALOVE AND MUDR. PETRA BELOHLAVKOVA (“Agreement”) PRVNÍ DODATEK KE SMLOUVĚ O KLINICKÉM HODNOCENÍ ZE DNE 24. října 2014 UZAVŘENÉMEZI Covance (dříve známé jako CHILTERN INTERNATIONAL, S.R.O.), FAKULTNÍ NEMOCNICÍ HRADEC KRÁLOVÉ A MUDR. PETROU BĚLOHLÁVKOVOU(dále jen „Smlouva“) THIS FIRST AMENDMENT TO CLINICAL TRIALAGREEMENT (this “Amendment”) is made and entered into by and betweenCovance Clinical and Periapproval Services Limited, Osprey House, Westacott Way, Maidenhead, SL6 3QH, UK, Registered in England, Company No 02022667, represented by , on the basis of Power of Attorney (hereinafter referred to as “Covance”); and Fakultní nemocnice Hradec Králové, Sokolská 581, 500 05 Hradec Králové – Nový Hradec Králové, Czech Republic, represented by: prof. MUDr. Vladimír Palička, CSc., dr. h. c, director, IČO: 00179906, DIČ: CZ00179906 (hereinafter refer